Safety of follow-up field application of ingenol mebutate 0.015% gel for actinic keratoses on face and scalp

被引：0
|
作者：
Garbe, Claus [1 ]
Basset-Seguin, Nicole [2 ]
Poulin, Yves [3 ]
Larsson, Thomas [4 ]
Knudsen, Kim Mark [4 ]
Lear, John [5 ]
机构：
[1] Univ Med Ctr Tuebingen, Tubingen, Germany
[2] Hop St Louis, Paris, France
[3] Univ Laval, Quebec City, PQ, Canada
[4] LEO Pharma AS, Ballerup, Denmark
[5] Manchester Royal Infirm, Manchester M13 9WL, Lancs, England
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2015年 / 72卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
604
引用
收藏
页码：AB191 / AB191
页数：1
相关论文
共 50 条
  • [1] Treatment of actinic keratoses and cancerization field of the face and scalp with 0.015% ingenol mebutate gel in Brazilian individuals: safety, tolerability and patients' perspectives
    Gameiro, Luiz
    Requejo Tovo, Luis Fernando
    Sanches Junior, Jose Antonio
    Aprahamian, Ivan
    ANAIS BRASILEIROS DE DERMATOLOGIA, 2019, 94 (03) : 313 - 319
  • [2] Efficacy and safety of ingenol mebutate 0.015% gel for actinic keratosis on the scalp
    Perez-Cabello, Gladys
    Martin, Modesto
    Lopez-Navarro, Norberto
    Castillo-Munoz, Rosa
    Juan Bosch-Garcia, Ricardo
    Herrera-Ceballos, Enrique
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB183 - AB183
  • [3] Safety and efficacy of ingenol mebutate gel 0.015%, for treatment of actinic keratoses on the face in solid organ transplant recipients
    Crow, Lauren D.
    Yuan, Joyce T.
    Aroyan, Christine S.
    Twigg, Amanda R.
    Singer, Jonathan P.
    Roll, Garrett R.
    Lazar, Ann A.
    Arron, Sarah T.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB270 - AB270
  • [4] Three-day topical treatment with ingenol mebutate gel, 0.015% for actinic keratoses on the face
    Berman, B.
    Marmur, E.
    Melgaard, A.
    Larsson, T.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2013, 11 : 109 - 109
  • [5] Long-term Follow-up Study of Ingenol Mebutate Gel for the Treatment of Actinic Keratoses
    Lebwohl, Mark
    Shumack, Stephen
    Gold, Linda Stein
    Melgaard, Anita
    Larsson, Thomas
    Tyring, Stephen K.
    JAMA DERMATOLOGY, 2013, 149 (06) : 666 - 670
  • [6] Treatment of actinic keratoses with ingenol mebutate 0.015% gel in solid organ transplant recipients
    Longo, I.
    Hernandez-Araguees, I.
    Vidal-Asensi, S.
    BRITISH JOURNAL OF DERMATOLOGY, 2014, 171 : 49 - 50
  • [7] Treatment of actinic keratoses with ingenol mebutate 0.015% gel in solid organ transplant recipients
    Longo, I.
    Hernandez-Araguees, I.
    Vidal-Asensi, S.
    BRITISH JOURNAL OF DERMATOLOGY, 2014, 171 (03) : E61 - E62
  • [8] Efficacy and safety of follow-up field treatment of actinic keratosis with ingenol mebutate 0.015% gel: a randomized, controlled 12-month study
    Garbe, C.
    Basset-Seguin, N.
    Poulin, Y.
    Larsson, T.
    Osterdal, M. L.
    Venkata, R.
    Lear, J. T.
    BRITISH JOURNAL OF DERMATOLOGY, 2016, 174 (03) : 505 - 513
  • [9] Ingenol mebutate gel, 0.015% repeat use for Multiple Actinic Keratoses on face and scalp: A review of the phase 3 clinical study rationale and design
    Garbe, C.
    Zibert, J. R.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2013, 11 : 131 - 131
  • [10] Ingenol Mebutate Gel 0.015% and 0.05% In Actinic Keratosis
    Keating, Gillian M.
    DRUGS, 2012, 72 (18) : 2397 - 2405
12345